{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:53:39Z","timestamp":1790481219600,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T00:00:00Z","timestamp":1543708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National High Technology Research and Development Program of China","award":["SS2015AA020405"],"award-info":[{"award-number":["SS2015AA020405"]}]},{"name":"National High Technology Research and Development Program of China","award":["SS2014AA020533"],"award-info":[{"award-number":["SS2014AA020533"]}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation of China","doi-asserted-by":"publisher","award":["LQ13H160006"],"award-info":[{"award-number":["LQ13H160006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Innovative Team for the Diagnosis and Treatment of Pancreatic Cancer of Zhejiang Province","award":["2013TD06"],"award-info":[{"award-number":["2013TD06"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81530079"],"award-info":[{"award-number":["81530079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302071"],"award-info":[{"award-number":["81302071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401954"],"award-info":[{"award-number":["81401954"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.biomaterials.2018.11.035","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T08:34:25Z","timestamp":1543566865000},"page":"590-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin"],"prefix":"10.1016","volume":"192","author":[{"given":"Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brayant Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangzhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2018.11.035_bib1","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib3","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib4","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/1535-7163.MCT-16-0050","article-title":"Concepts to target MYC in pancreatic cancer","volume":"15","author":"Wirth","year":"2016","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/gutjnl-2016-312539","article-title":"Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?","volume":"66","author":"Hessmann","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrd4503","article-title":"A holistic approach to targeting disease with polymeric nanoparticles","volume":"14","author":"Cheng","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrclinonc.2016.119","article-title":"Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer","volume":"13","author":"Adiseshaiah","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib8","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1021\/ar200256e","article-title":"Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides","volume":"45","author":"Nakase","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib9","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1016\/j.biomaterials.2013.02.039","article-title":"Peptide-mediated intracellular delivery of miRNA-29b for osteogenic stem cell differentiation","volume":"34","author":"Suh","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jconrel.2010.01.009","article-title":"RNA interference in vitro and in vivo using an arginine peptide\/siRNA complex system","volume":"143","author":"Kim","year":"2010","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib12","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1039\/C4CC01061B","article-title":"Biocompatible, chimeric peptide-condensed supramolecular nanoparticles for tumor cell-specific siRNA delivery and gene silencing","volume":"50","author":"Wang","year":"2014","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib16","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/S1470-2045(12)70073-6","article-title":"microRNAs in cancer management","volume":"13","author":"Kong","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrd4359","article-title":"Therapeutic targeting of microRNAs: current status and future challenges","volume":"13","author":"Li","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib18","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1371\/journal.pmed.0050085","article-title":"Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma","volume":"5","author":"Kelly","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1158\/1078-0432.CCR-10-0999","article-title":"Plectin-1 as a novel biomarker for pancreatic cancer","volume":"17","author":"Bausch","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib20","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1158\/0008-5472.CAN-09-3341","article-title":"miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED","volume":"70","author":"Incoronato","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-015-0443-9","article-title":"Aryl hydrocarbon receptor-microRNA-212\/132 axis in human breast cancer suppresses metastasis by targeting SOX4","volume":"14","author":"Hanieh","year":"2015","journal-title":"Mol. Canc."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ijc.25126","article-title":"miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer","volume":"127","author":"Wada","year":"2010","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.gastro.2013.04.004","article-title":"Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD","volume":"145","author":"Meng","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2015.03.001","article-title":"WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation","volume":"361","author":"Liu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/CBM-160671","article-title":"Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma","volume":"18","author":"Wu","year":"2017","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib26","doi-asserted-by":"crossref","first-page":"29877","DOI":"10.18632\/oncotarget.4924","article-title":"Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1756-9966-33-54","article-title":"miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1","volume":"33","author":"Ma","year":"2014","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbrc.2011.02.065","article-title":"miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor","volume":"406","author":"Park","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib30","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1158\/1078-0432.CCR-07-0078","article-title":"A new model of patient tumor-derived breast cancer xenografts for preclinical assays","volume":"13","author":"Marangoni","year":"2007","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib31","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ymthe.2016.11.016","article-title":"RNA nanoparticle-based targeted therapy for glioblastoma through inhibition of oncogenic miR-21","volume":"25","author":"Lee","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib32","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.7150\/thno.20771","article-title":"Nanoparticle delivery of miR-34a eradicates long-term-cultured breast cancer stem cells via targeting C22ORF28 directly","volume":"7","author":"Lin","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","article-title":"Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms","volume":"100","author":"Aird","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/bc100070g","article-title":"Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects","volume":"21","author":"Maeda","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib36","doi-asserted-by":"crossref","first-page":"a016980","DOI":"10.1101\/cshperspect.a016980","article-title":"Exploiting endocytosis for nanomedicines","volume":"5","author":"Akinc","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nature11114","article-title":"The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma","volume":"486","author":"P\u00e9rez-Mancera","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156800909788166547","article-title":"Anti-apoptotic mechanisms of drug resistance in cancer","volume":"9","author":"Wilson","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biomaterials.2018.11.035_bib40","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The role of autophagy in cancer: therapeutic implications","volume":"10","author":"Yang","year":"2011","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib41","doi-asserted-by":"crossref","first-page":"14866","DOI":"10.1038\/ncomms14866","article-title":"USP9X regulates centrosome duplication and promotes breast carcinogenesis","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib42","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1158\/1535-7163.MCT-10-1091","article-title":"Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.biomaterials.2018.11.035_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218308202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218308202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:43:24Z","timestamp":1758905004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961218308202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":43,"alternative-id":["S0142961218308202"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.11.035","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}